The Manchester spinout is trialling treatment systems to remove organic and microbial waste from water more efficiently.
Arvia Technology, a UK-based waste treatment developer spun out from University of Manchester, today secured follow-on funding of undisclosed size from the Parkwalk Opportunities Fund.
Parkwalk Opportunities Fund is managed by commercialisation firm Parkwalk Advisors under the UK government’s Enterprise Investment Scheme VC tax assistance program.
Arvia has developed a treatment system to remove organic and microbial waste from water by converting the pollutants into gas. The technology is currently undergoing testing at nuclear production sites and can work alongside conventional water treatments.
The spinout had received $17m in total funding prior to the latest round, according to deals database PitchBook, including $4.5m raised in 2013 and $5.9m from Parkwalk one year earlier. Parkwalk later contributed an unspecified sum in 2015, in a round led by an unnamed investor.
